Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Provide of brief overview of the pharmaceuticalindustry, focusing on Generic Drugs and Prodrugs
View through CrossRef
The pharmaceutical industry is a cornerstone of
modern healthcare, driving the discovery,
development, and distribution of medications that
treat, prevent, and manage diseases. Within this
expansive field, generic drugs and prodrugs
occupy critical roles in enhancing drug accessibility
and therapeutic performance, respectively. Generic
drugs offer cost-effective alternatives to brandname medications by ensuring bioequivalence and
quality, thereby reducing healthcare costs and
expanding global access. In contrast, prodrugs
represent a strategic innovation designed to
optimize pharmacokinetic and pharmacodynamic
properties through chemical modification,
ultimately improving drug absorption, distribution,
metabolism, and excretion (ADME). This review
provides a comprehensive overview of the
pharmaceutical industry with a specific focus on
the development, regulatory framework, benefits,
and challenges associated with generic drugs and
prodrugs. It further explores future directions in
these domains, highlighting their significance in
advancing patient-centric and economically
sustainable pharmaceutical care.Two specialized
categories within this domain—generic drugs and
prodrugs—serve essential roles in expanding
access and improving therapeutic outcomes. While
generic drugs offer cost-effective alternatives to
branded medications, prodrugs provide a strategic
approach to overcoming pharmacokinetic
limitations and optimizing drug delivery
Title: Provide of brief overview of the pharmaceuticalindustry, focusing on Generic Drugs and Prodrugs
Description:
The pharmaceutical industry is a cornerstone of
modern healthcare, driving the discovery,
development, and distribution of medications that
treat, prevent, and manage diseases.
Within this
expansive field, generic drugs and prodrugs
occupy critical roles in enhancing drug accessibility
and therapeutic performance, respectively.
Generic
drugs offer cost-effective alternatives to brandname medications by ensuring bioequivalence and
quality, thereby reducing healthcare costs and
expanding global access.
In contrast, prodrugs
represent a strategic innovation designed to
optimize pharmacokinetic and pharmacodynamic
properties through chemical modification,
ultimately improving drug absorption, distribution,
metabolism, and excretion (ADME).
This review
provides a comprehensive overview of the
pharmaceutical industry with a specific focus on
the development, regulatory framework, benefits,
and challenges associated with generic drugs and
prodrugs.
It further explores future directions in
these domains, highlighting their significance in
advancing patient-centric and economically
sustainable pharmaceutical care.
Two specialized
categories within this domain—generic drugs and
prodrugs—serve essential roles in expanding
access and improving therapeutic outcomes.
While
generic drugs offer cost-effective alternatives to
branded medications, prodrugs provide a strategic
approach to overcoming pharmacokinetic
limitations and optimizing drug delivery.
Related Results
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Abstract
Funding Acknowledgements
Type of funding sources: None.
INTRODUCTION Patients with heart failure (HF)...
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Background: The design and development of prodrugs is the most common and effective strategy to overcome pharmacokinetic and pharmacodynamic drawbacks of active drugs. A respected ...
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
...
Recent Advances in Prodrug Approach over Conventional Drug Therapy
Recent Advances in Prodrug Approach over Conventional Drug Therapy
Background:
Prodrugs represent a strategically designed category of medicinal compounds
aimed at optimizing drug pharmacokinetics. By modifying the pharmacological action of the
dr...
Overcoming Barriers to Generic Drug Adoption: Insights from Global Studies
Overcoming Barriers to Generic Drug Adoption: Insights from Global Studies
Objective: This review paper aims to provide insights into the awareness of generic drugs among consumers, challenges in the adoption of generic drugs identified in various studies...
Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
This review supplies the reader with a detailed overview on the utilization of intramolecular processes
for a design and synthesis of prodrugs. It is well known that a respected nu...
A Study on the Dispensing Pattern of OTC Medications in Community Pharmacies: Generic versus Non-Generic drugs
A Study on the Dispensing Pattern of OTC Medications in Community Pharmacies: Generic versus Non-Generic drugs
Over the Counter (OTC) Drugs are legally allowed to be sold 'Over the Counter' without the prescription of a registered medical practitioner (RMP). The study aimed to assess the dr...
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
AbstractThe clinical approval of platinum‐based drugs has prompted the development of novel metallo‐complexes during the last several decades, while severe problems, especially for...